- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Live Cell Imaging market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.0% during the forecast period.
This report presents the market size and development trends by detailing the Live Cell Imaging market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Live Cell Imaging market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Live Cell Imaging industry and will help you to build a panoramic view of the industrial development.
Live Cell Imaging Market, By Type:
Equipment
Consumables
Live Cell Imaging Market, By Application:
Cell Biology
Stem Cells
Developmental Biology
Drug Discovery
Some of the leading players are as follows:
GE Healthcare (U.K.)
Molecular Devices, LCC (U.S.)
Leica Microsystems (Germany)
CytoSMART Technologies (Netherlands)
PerkinElmer, Inc (US)
PerkinElmer, Inc. (U.S.)
Becton, Dickinson and Company (U.S.)
Olympus Corporation (Japan)
Sigma Aldrich Corporation (U.S.)
Thermo Fisher Scientific, Inc.(U.S.)
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Live Cell Imaging Market: Technology Type Analysis
-
4.1 Live Cell Imaging Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Live Cell Imaging Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Equipment
4.3.2 Consumables
5 Live Cell Imaging Market: Product Analysis
-
5.1 Live Cell Imaging Product Market Share Analysis, 2018 & 2026
-
5.2 Live Cell Imaging Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Live Cell Imaging Market: Application Analysis
-
6.1 Live Cell Imaging Application Market Share Analysis, 2018 & 2026
-
6.2 Live Cell Imaging Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Cell Biology
6.3.2 Stem Cells
6.3.3 Developmental Biology
6.3.4 Drug Discovery
7 Live Cell Imaging Market: Regional Analysis
-
7.1 Live Cell Imaging Regional Market Share Analysis, 2018 & 2026
-
7.2 Live Cell Imaging Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 GE Healthcare (U.K.)
9.1.1 GE Healthcare (U.K.) Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Molecular Devices, LCC (U.S.)
9.2.1 Molecular Devices, LCC (U.S.) Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Leica Microsystems (Germany)
9.3.1 Leica Microsystems (Germany) Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 CytoSMART Technologies (Netherlands)
9.4.1 CytoSMART Technologies (Netherlands) Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 PerkinElmer, Inc (US)
9.5.1 PerkinElmer, Inc (US) Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 PerkinElmer, Inc. (U.S.)
9.6.1 PerkinElmer, Inc. (U.S.) Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Becton, Dickinson and Company (U.S.)
9.7.1 Becton, Dickinson and Company (U.S.) Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Olympus Corporation (Japan)
9.8.1 Olympus Corporation (Japan) Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Sigma Aldrich Corporation (U.S.)
9.9.1 Sigma Aldrich Corporation (U.S.) Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Thermo Fisher Scientific, Inc.(U.S.)
9.10.1 Thermo Fisher Scientific, Inc.(U.S.) Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 79 Figures and 146 Tables)
Figure Equipment Live Cell Imaging market, 2015 - 2026 (USD Million)
Figure Consumables Live Cell Imaging market, 2015 - 2026 (USD Million)
Figure Cell Biology market, 2015 - 2026 (USD Million)
Figure Stem Cells market, 2015 - 2026 (USD Million)
Figure Developmental Biology market, 2015 - 2026 (USD Million)
Figure Drug Discovery market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Live Cell Imaging market, by country, 2015 - 2026 (USD Million)
-
Table North America Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table North America Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table North America Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table Canada Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table Canada Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Europe Live Cell Imaging market, by country, 2015 - 2026 (USD Million)
-
Table Europe Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table Europe Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table Europe Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table Germany Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table Germany Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table France Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table France Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table Italy Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table Italy Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table Spain Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table Spain Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Live Cell Imaging market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table China Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table China Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table Japan Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table Japan Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table India Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table India Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Live Cell Imaging market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table MEA Live Cell Imaging market, by country, 2015 - 2026 (USD Million)
-
Table MEA Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table MEA Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table MEA Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Live Cell Imaging market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Live Cell Imaging market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Live Cell Imaging market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table GE Healthcare (U.K.) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Molecular Devices, LCC (U.S.) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Leica Microsystems (Germany) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CytoSMART Technologies (Netherlands) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PerkinElmer, Inc (US) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PerkinElmer, Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Becton, Dickinson and Company (U.S.) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Olympus Corporation (Japan) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sigma Aldrich Corporation (U.S.) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Thermo Fisher Scientific, Inc.(U.S.) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-

Chinese